PT United Tractors Tbk (UNTR) will pay dividends of Rp 2.31 trillion, or Rp 620 per share to shareholders. Issuer’s stock dividend UNTR coded 40% of net income in 2012 which reached Rp 5.78 trillion.
“Distribution of cash dividends amounting to Rp 620 per share, including the interim dividend of Rp 210 per share,” said Secretary Sara Loebis United Tractor Company after the General Meeting of Shareholders Year (AGM) Hotel Ritz Carlton Pacific Place, Jakarta, Monday (22 / 4/2013).
The interim dividend was paid on 2 November 2012, while the remaining Rp 410 per share will be paid on May 31, 2013.
“In addition to dividends, the shareholders also approved the residual net income after dividend will be recorded as income in the resistance,” he added.
In the same place, Finance Director of United Tractor Gidion Hasan said, the company is ready to pour the period 2013 capital expenditure (capex) of U.S. $ 230 million.
“Most of the U.S. $ 197 million to our subsidiary PT Nusantara Pamapersada (Coal Mine),” he said.
United Tractor currently has three business units namely the type of Komatsu heavy equipment sales, contractor mining, and coal mining concession. This year, a subsidiary of PT Astra International Tbk is planning to enter the ship-care industry.
United Tractor at this year expects to sell 5,000 units of weight or decrease of the period amounted to 6,200 units sebelunya. This decrease occurs because the coal and oil commodity prices are still volatile.
Jakarta – President Director of PT. Semen Indonesia Tbk Soetjipto said the company examines global bonds worth U.S. $ 300 million or Rp 2.98 trillion. The plan that bonds will be issued next year. “It’s an investment for next year,” he said when met after the event Bisnis Indonesia, Tuesday evening, July 2, 2013.
The Company requires capital expenditure of U.S. $ 500 million – U.S. $ 600 million next year. Half of it comes from the need of external funding is through the issuance of bonds. “For this year we are still strong power of cash.”
Capital expenditure was used to build two new factories in Apex, Central Java, and Indarung, West Sumatra. Some will be used to finance business expansion plans into Myanmar and Vietnam.
Factory in Vietnam built with a production capacity of 2.3 million tons. The investment value of Rp 1.5 trillion in the form of investment of 70 percent ownership stake Thang Long Cement.
The Company is considering a rate cut option Thang Long Cement factory in Vietnam that is too high. “Hopefully in the near future could have taken a decision,” he said.
The plant began operations in Myanmar next year. The investment value of U.S. $ 200 million. The plant production capacity of 6.5 million tons per year. “This new subsidiary with local companies Myanmar, our ownership share of 51 percent minimum,” said Dwi.
This year the company is targeting sales volume in 2013 amounted to 28 million tons, and the company’s 44 percent market share.
Capex this year of Rp 4 trillion. Sources of funding capital expenditure is 40 per cent and 60 per cent internal funds from bank loans.
PT Kalbe Farma, drug manufacturers and national health supplements, plans to build a dairy factory in the Cikampek, West Java. According to the Director of Finance and Corporate Secretary of Kalbe Farma, Vidjongtius, the plant cost around Rp 300 billion. “The project started in 2014,” he said at a media gathering.
Vidjongtius said the plant will be owned by the installation of a fourth milk production Kalbe Farma. With the construction of this plant, Kalbe increase milk production capacity of 12 thousand tons to 24 thousand tons per year.
Funds to build the plant will be met from capital expenditure Kalbe Farma in 2013, which reached Rp 1.5 trillion. According Vidjongtius, until the first half, the company has spent at least 40 percent of the annual capital expenditure. “The new plant is expected to support business growth in the future,” he said.
In 2012, Kalbe has completed the construction of dairy factory in Sukabumi, West Java. This plant is the result of cooperation with PT Milko Beverage Industry. Kalbe, which poured an investment of Rp 154 billion, became the majority owner with 51 percent parts.
Throughout 2013, Kalbe targeting revenue growth and net income by 18 percent. That figure is above the growth of the pharmaceutical industry which reached 15 percent. In 2012, Kalbe Farma pocketed a net profit of Rp 1.73 trillion and Rp 13.6 trillion in net sales. Thus, the company targets a net profit of Rp 2.04 trillion and Rp 16 trillion in net sales in 2013.